Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 17/8/2017
SIETES contiene 91969 citas

 1 a 12 de 12 
Presentar resultados
Seleccionar todas
1. Cita con resumen
Goldacre B, Lane S, Mahtani KR, Heneghan C, Onakpoya I, Bushfield I, Smeeth L. Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study. BMJ 2017;358:j3334. [Ref.ID 101997]
2. Cita con resumen
Goldacre B. The WHO joint statement from funders on trials transparency. BMJ 2017;357:j2816. [Ref.ID 101660]
3. Cita con resumen
Naci H, Lehman R, Wouters OJ, Goldacre B, Yudkin JS. Rethinking the appraisal and approval of drugs for type 2 diabetes. BMJ 2015;351:h5260. [Ref.ID 99594]
4. Cita con resumen
Goldacre B, Godlee F, Heneghan C, Tovey D, Lehman R, Chalmers I, Barbour V, Brown T. EMA should remove barriers to access clinical trial data. BMJ 2014;348:g3768. [Ref.ID 98042]
5. Cita con resumen
Finegold JA, Manisti CH, Goldacre B, Barron AJ, Francis DP. What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice. European Journal of Preventive Cardiology 2014;21:464-74. [Ref.ID 97504]
Goldacre B, Heneghan C. Improving, and auditing, access to clinical trial results. BMJ 2014;348:g213. [Ref.ID 97233]
7.Tiene citas relacionadas Cita con resumen
Goldacre B. Are clinical trial data shared sufficiently today? No. BMJ 2013;347:16-7. [Ref.ID 96129]
8.Tiene citas relacionadas
Goldacre B, Spiegelhalter D. Bicycle helmets and the law. BMJ 2013;346:10. [Ref.ID 95924]
9. Cita con resumen
Handel AE, Patel SV, Pakpoor J, Ebers GC, Goldacre B, Ramagopalan SV. High reprint orders in medical journals and pharmaceutical industry funding: case-control study. BMJ 2012;345:20. [Ref.ID 93394]
10. Cita con resumen
van Staa TP, Goldacre B, Gulliford M, Cassell J, Pirmohamed M, Taweel A, Delaney B, Smeeth L. Pragmatic randomised trials using routine electronic health records. BMJ 2012;344:22-5. [Ref.ID 92355]
12.Tiene citas relacionadas
Goldacre B. Benefits and risks of homoeopathy. Lancet 2007;370:1672-3. [Ref.ID 81555]
Seleccionar todas
 1 a 12 de 12